Paradigm Asset Management CO LLC Bio Techne Corp Transaction History

Paradigm Asset Management CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$246.9 - $321.87 $246,900 - $321,870	-1,000 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$185.43 - $279.56 $101,986 - $153,758	550 Added 122.22%	1,000 $264,000
Q2 2019 Aug 08, 2019	BUY	$188.72 - $215.43 $56,616 - $64,629	300 Added 200.0%	450 $0
Q1 2019 May 14, 2019	SELL	$136.09 - $200.44 $20,413 - $30,066	-150 Reduced 50.0%	150 $0
Q4 2018 Feb 14, 2019	BUY	$132.75 - $203.8 $6,637 - $10,190	50 Added 20.0%	300 $43,000
Q3 2018 Nov 19, 2018	SELL	$147.44 - $204.11 $7,372 - $10,205	-50 Reduced 16.67%	250 $0
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $34,077 - $37,134	300	300 $0

616

156M

200K

15.3K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.59B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Paradigm Asset Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Paradigm Asset Management CO LLC with notifications on news.